Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra M Harrington

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Leukemia Research Reports|June 2, 2022
Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndromeKristen Corrao, Siam Rezwan, Ehab Atallah, et al.
Cytometry. Part B, Clinical Cytometry|April 5, 2011
Immunophenotypic signatures of benign and dysplastic granulopoiesis by cytomic profilingWilliam G Finn, Alexandra M Harrington, Kevin M Carter, et al.
Annals of Diagnostic Pathology|August 16, 2017
Evaluation of CD43 expression in non-hematopoietic malignanciesBjorn H Batdorf, Steven H Kroft, Paul R Hosking, et al.
American Journal of Clinical Pathology|November 11, 2017
CD30 Expression in Monomorphic Posttransplant Lymphoproliferative Disorder, Diffuse Large B-Cell Lymphoma Correlates With Greater Regulatory T-Cell InfiltrationChristopher Hartley, James W Vaughan, Jason Jarzembowski, et al.
JACC. Case Reports|December 12, 2025
Multiorgan Peripheral T-Cell Lymphoma Presenting as Isolated CardiomyopathyAbdullah A Memon, Eric Darrah, Ty Monty, et al.
Therapeutic Advances in Hematology|February 4, 2014
Rituximab is associated with improved survival in Burkitt lymphoma: a retrospective analysis from two US academic medical centersTanya M Wildes, Laura Farrington, Cecilia Yeung, et al.
American Journal of Clinical Pathology|April 29, 2016
Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid NeoplasmsHongmei Li, Robert P Hasserjian, Steven H Kroft, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 11, 2016
Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on SurvivalBinod Dhakal, Anita D'Souza, Michael Martens, et al.
Thrombosis Research|February 28, 2026
Implementation of institutional thrombophilia guidelines and electronic medical record tools to reduce inpatient thrombophilia testing and costsMuhammad Mubbashir Sheikh, Hatim Attar, Diane Book, et al.
Leukemia & Lymphoma|September 21, 2020
Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemiaMuhammad Umair Mushtaq, Alexandra M Harrington, Sibgha Gull Chaudhary, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Leukemia Research Reports|June 2, 2022
Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndromeKristen Corrao, Siam Rezwan, Ehab Atallah, et al.
Cytometry. Part B, Clinical Cytometry|April 5, 2011
Immunophenotypic signatures of benign and dysplastic granulopoiesis by cytomic profilingWilliam G Finn, Alexandra M Harrington, Kevin M Carter, et al.
Annals of Diagnostic Pathology|August 16, 2017
Evaluation of CD43 expression in non-hematopoietic malignanciesBjorn H Batdorf, Steven H Kroft, Paul R Hosking, et al.
American Journal of Clinical Pathology|November 11, 2017
CD30 Expression in Monomorphic Posttransplant Lymphoproliferative Disorder, Diffuse Large B-Cell Lymphoma Correlates With Greater Regulatory T-Cell InfiltrationChristopher Hartley, James W Vaughan, Jason Jarzembowski, et al.
JACC. Case Reports|December 12, 2025
Multiorgan Peripheral T-Cell Lymphoma Presenting as Isolated CardiomyopathyAbdullah A Memon, Eric Darrah, Ty Monty, et al.
Therapeutic Advances in Hematology|February 4, 2014
Rituximab is associated with improved survival in Burkitt lymphoma: a retrospective analysis from two US academic medical centersTanya M Wildes, Laura Farrington, Cecilia Yeung, et al.
American Journal of Clinical Pathology|April 29, 2016
Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid NeoplasmsHongmei Li, Robert P Hasserjian, Steven H Kroft, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 11, 2016
Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on SurvivalBinod Dhakal, Anita D'Souza, Michael Martens, et al.
Thrombosis Research|February 28, 2026
Implementation of institutional thrombophilia guidelines and electronic medical record tools to reduce inpatient thrombophilia testing and costsMuhammad Mubbashir Sheikh, Hatim Attar, Diane Book, et al.
Leukemia & Lymphoma|September 21, 2020
Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemiaMuhammad Umair Mushtaq, Alexandra M Harrington, Sibgha Gull Chaudhary, et al.
Pageof 5